Region (Europe as reference group)
|
1.616
|
1.116; 2.355
|
0.011
|
0.248
|
0.212; 0.290
|
<0.001
|
Age (per year)
|
1.038
|
1.006; 1.072
|
0.020
|
1.012
|
1.001; 1.023
|
0.032
|
Sex (male as reference group)
|
0.542
|
0.311; 1.009
|
0.053
|
0.535
|
0.444; 0.644
|
<0.001
|
Diabetes duration (per year)
|
1.011
|
0.989; 1.035
|
0.330
|
1.004
|
0.995; 1.013
|
0.358
|
Race (white as reference group)
|
Asian
|
0.632
|
0.136; 3.479
| |
1.226
|
0.664; 2.275
| |
Black
|
0.710
|
0.371; 1.339
|
0.633
|
0.773
|
0.581; 1.023
|
0.226
|
Other
|
1.53
|
0.313; 8.783
| |
0.759
|
0.389; 1.451
| |
BMI (18–25, reference group) (kg/m2)
|
25–30
|
0.571
|
0.239; 1.298
| |
1.029
|
0.735; 1.438
| |
30–35
|
0.836
|
0.353; 1.884
|
0.224
|
1.083
|
0.778; 1.503
|
0.472
|
35–40
|
0.879
|
0.361;2.049
| |
1.105
|
0.782; 1.560
| |
>40
|
0.935
|
0.375; 2.246
| |
1.287
|
0.891; 1.856
| |
Statin use (no as reference)
|
4.669
|
3.352; 6.550
|
<0.001
|
4.276
|
3.526; 5.202
|
<0.001
|
Aspirin use (no as reference)
|
1.055
|
0.750; 1.482
|
0.759
|
1.369
|
1.174; 1.597
|
<0.001
|
Creatinine, per umol/L
|
1.007
|
0.982; 1.038
|
0.607
|
0.995
|
0.991; 1.000
|
0.034
|
ACR, per mg/mmol
|
0.999
|
0.995; 1.003
|
0.485
|
0.999
|
0.997; 1.000
|
0.017
|
eGFR per mL/min/1.73 m2
|
1.006
|
0.993; 1.025
|
0.360
|
0.994
|
0.988; 1.000
|
0.036
|